ZBH Stock: Zimmer Biomet Holdings, Inc. Stock Price, Analysis & Insights
Get live zbh stock price $88.64, comprehensive Zimmer Biomet Holdings, Inc. stock analysis, charts, news, and expert forecast. Real-time zbh stock data and investment insights.
Loading chart...
Company Overview
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Company Information
- CEO
- Ivan Tornos
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 17000
Contact Information
- Website
- https://www.zimmerbiomet.com
- Address
- 345 East Main Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 22.0)
✓ Lower volatility stock (Beta: 0.61) may provide portfolio stability
Business Model & Strategy
Zimmer Biomet Holdings, Inc. operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Ivan Tornos, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Zimmer Biomet Holdings, Inc. competes in the Medical - Devices within the broader Healthcare. With 17.6 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Zimmer Biomet Holdings, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Zimmer Biomet Holdings, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Zimmer Biomet Holdings, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Zimmer Biomet Holdings, Inc.
- ⚠Investors should consider how Zimmer Biomet Holdings, Inc. fits within their overall portfolio allocation
Market Cap
17.57B
P/E Ratio
22.00
Beta
0.61
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 17.57B market capitalization
- Trading Volume: 2.44M shares traded today
- Price Range: 52-week range of $85.33 - $114.72
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 17.57B, the company represents a significant player in its market. The stock is currently trading at $88.64 with a negativedaily change of 1.41%.
The company's 17000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 22.00, beta of 0.61, and 52-week price range from $85.33 to $114.72when evaluating investment opportunities.
Why Invest in Zimmer Biomet Holdings, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Ivan Tornos
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.